Shortage of Adderall and other ADHD drugs expected to last through 2024, despite federal attempts to fix it
CLEVELAND, Ohio — The nationwide shortage of Adderall and related drugs, used to treat attention/deficit hyperactivity disorder, has passed the year mark with no end in sight. High demand — from increased access to the medication via telehealth to people with long COVID-19 using ADHD drugs — makes the situation worse.
Other Articles in this Edition
People taking ADHD medications should closely monitor their heart health, study suggests
Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD
New study sheds light on ADHD’s impact on motivation and the efficacy of amphetamine-based meds
Microdosing psychedelics shows promise for improving mindfulness in adults with ADHD
Texas AG sues Pfizer over quality-control lapses in kids’ ADHD drug
US Limit on a Key ADHD Drug Is Worsening Shortages, Group Says
Diagnosed With ADHD — What Should I Do Now?
What it’s like to be diagnosed with ADHD as an adult in China